DNA Sequencing Market Size & Trends Analysis Report

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global DNA Sequencing Market Size Analysis

Global DNA Sequencing Market Introduction
By Offerings
1. Introduction
  1. Offerings By Value
2. Consumables
  1. By Value
3. Instruments
  1. By Value
4. Services
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Sanger Sequencing
  1. By Value
3. Next-Generation Sequencing
  1. By Value
4. Third Generation DNA Sequencing
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Oncology
  1. By Value
3. Clinical investigation
  1. By Value
4. Agrigenomics & forensics
  1. By Value
5. HLA typing/immune system monitoring
  1. By Value
6. Drug development
  1. By Value
7. Others
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Academic Research
  1. By Value
3. Clinical Research
  1. By Value
4. Hospitals & Clinics
  1. By Value
5. Pharmaceutical & Biotechnology Companies
  1. By Value
6. Others
  1. By Value

North America Market Analysis

Introduction
By Offerings
1. Introduction
  1. Offerings By Value
2. Consumables
  1. By Value
3. Instruments
  1. By Value
4. Services
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Sanger Sequencing
  1. By Value
3. Next-Generation Sequencing
  1. By Value
4. Third Generation DNA Sequencing
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Oncology
  1. By Value
3. Clinical investigation
  1. By Value
4. Agrigenomics & forensics
  1. By Value
5. HLA typing/immune system monitoring
  1. By Value
6. Drug development
  1. By Value
7. Others
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Academic Research
  1. By Value
3. Clinical Research
  1. By Value
4. Hospitals & Clinics
  1. By Value
5. Pharmaceutical & Biotechnology Companies
  1. By Value
6. Others
  1. By Value
U.S.
1. By Offerings
  1. Introduction
    1. Offerings By Value
  2. Consumables
    1. By Value
  3. Instruments
    1. By Value
  4. Services
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Sanger Sequencing
    1. By Value
  3. Next-Generation Sequencing
    1. By Value
  4. Third Generation DNA Sequencing
    1. By Value
3. By Applications
  1. Introduction
    1. Applications By Value
  2. Oncology
    1. By Value
  3. Clinical investigation
    1. By Value
  4. Agrigenomics & forensics
    1. By Value
  5. HLA typing/immune system monitoring
    1. By Value
  6. Drug development
    1. By Value
  7. Others
    1. By Value
4. By End-User
  1. Introduction
    1. End-User By Value
  2. Academic Research
    1. By Value
  3. Clinical Research
    1. By Value
  4. Hospitals & Clinics
    1. By Value
  5. Pharmaceutical & Biotechnology Companies
    1. By Value
  6. Others
    1. By Value
Canada

Europe Market Analysis

Introduction
By Offerings
1. Introduction
  1. Offerings By Value
2. Consumables
  1. By Value
3. Instruments
  1. By Value
4. Services
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Sanger Sequencing
  1. By Value
3. Next-Generation Sequencing
  1. By Value
4. Third Generation DNA Sequencing
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Oncology
  1. By Value
3. Clinical investigation
  1. By Value
4. Agrigenomics & forensics
  1. By Value
5. HLA typing/immune system monitoring
  1. By Value
6. Drug development
  1. By Value
7. Others
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Academic Research
  1. By Value
3. Clinical Research
  1. By Value
4. Hospitals & Clinics
  1. By Value
5. Pharmaceutical & Biotechnology Companies
  1. By Value
6. Others
  1. By Value
U.K.
1. By Offerings
  1. Introduction
    1. Offerings By Value
  2. Consumables
    1. By Value
  3. Instruments
    1. By Value
  4. Services
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Sanger Sequencing
    1. By Value
  3. Next-Generation Sequencing
    1. By Value
  4. Third Generation DNA Sequencing
    1. By Value
3. By Applications
  1. Introduction
    1. Applications By Value
  2. Oncology
    1. By Value
  3. Clinical investigation
    1. By Value
  4. Agrigenomics & forensics
    1. By Value
  5. HLA typing/immune system monitoring
    1. By Value
  6. Drug development
    1. By Value
  7. Others
    1. By Value
4. By End-User
  1. Introduction
    1. End-User By Value
  2. Academic Research
    1. By Value
  3. Clinical Research
    1. By Value
  4. Hospitals & Clinics
    1. By Value
  5. Pharmaceutical & Biotechnology Companies
    1. By Value
  6. Others
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Offerings
1. Introduction
  1. Offerings By Value
2. Consumables
  1. By Value
3. Instruments
  1. By Value
4. Services
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Sanger Sequencing
  1. By Value
3. Next-Generation Sequencing
  1. By Value
4. Third Generation DNA Sequencing
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Oncology
  1. By Value
3. Clinical investigation
  1. By Value
4. Agrigenomics & forensics
  1. By Value
5. HLA typing/immune system monitoring
  1. By Value
6. Drug development
  1. By Value
7. Others
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Academic Research
  1. By Value
3. Clinical Research
  1. By Value
4. Hospitals & Clinics
  1. By Value
5. Pharmaceutical & Biotechnology Companies
  1. By Value
6. Others
  1. By Value
China
1. By Offerings
  1. Introduction
    1. Offerings By Value
  2. Consumables
    1. By Value
  3. Instruments
    1. By Value
  4. Services
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Sanger Sequencing
    1. By Value
  3. Next-Generation Sequencing
    1. By Value
  4. Third Generation DNA Sequencing
    1. By Value
3. By Applications
  1. Introduction
    1. Applications By Value
  2. Oncology
    1. By Value
  3. Clinical investigation
    1. By Value
  4. Agrigenomics & forensics
    1. By Value
  5. HLA typing/immune system monitoring
    1. By Value
  6. Drug development
    1. By Value
  7. Others
    1. By Value
4. By End-User
  1. Introduction
    1. End-User By Value
  2. Academic Research
    1. By Value
  3. Clinical Research
    1. By Value
  4. Hospitals & Clinics
    1. By Value
  5. Pharmaceutical & Biotechnology Companies
    1. By Value
  6. Others
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Offerings
1. Introduction
  1. Offerings By Value
2. Consumables
  1. By Value
3. Instruments
  1. By Value
4. Services
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Sanger Sequencing
  1. By Value
3. Next-Generation Sequencing
  1. By Value
4. Third Generation DNA Sequencing
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Oncology
  1. By Value
3. Clinical investigation
  1. By Value
4. Agrigenomics & forensics
  1. By Value
5. HLA typing/immune system monitoring
  1. By Value
6. Drug development
  1. By Value
7. Others
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Academic Research
  1. By Value
3. Clinical Research
  1. By Value
4. Hospitals & Clinics
  1. By Value
5. Pharmaceutical & Biotechnology Companies
  1. By Value
6. Others
  1. By Value
UAE
1. By Offerings
  1. Introduction
    1. Offerings By Value
  2. Consumables
    1. By Value
  3. Instruments
    1. By Value
  4. Services
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Sanger Sequencing
    1. By Value
  3. Next-Generation Sequencing
    1. By Value
  4. Third Generation DNA Sequencing
    1. By Value
3. By Applications
  1. Introduction
    1. Applications By Value
  2. Oncology
    1. By Value
  3. Clinical investigation
    1. By Value
  4. Agrigenomics & forensics
    1. By Value
  5. HLA typing/immune system monitoring
    1. By Value
  6. Drug development
    1. By Value
  7. Others
    1. By Value
4. By End-User
  1. Introduction
    1. End-User By Value
  2. Academic Research
    1. By Value
  3. Clinical Research
    1. By Value
  4. Hospitals & Clinics
    1. By Value
  5. Pharmaceutical & Biotechnology Companies
    1. By Value
  6. Others
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Offerings
1. Introduction
  1. Offerings By Value
2. Consumables
  1. By Value
3. Instruments
  1. By Value
4. Services
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Sanger Sequencing
  1. By Value
3. Next-Generation Sequencing
  1. By Value
4. Third Generation DNA Sequencing
  1. By Value
By Applications
1. Introduction
  1. Applications By Value
2. Oncology
  1. By Value
3. Clinical investigation
  1. By Value
4. Agrigenomics & forensics
  1. By Value
5. HLA typing/immune system monitoring
  1. By Value
6. Drug development
  1. By Value
7. Others
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Academic Research
  1. By Value
3. Clinical Research
  1. By Value
4. Hospitals & Clinics
  1. By Value
5. Pharmaceutical & Biotechnology Companies
  1. By Value
6. Others
  1. By Value
Brazil
1. By Offerings
  1. Introduction
    1. Offerings By Value
  2. Consumables
    1. By Value
  3. Instruments
    1. By Value
  4. Services
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Sanger Sequencing
    1. By Value
  3. Next-Generation Sequencing
    1. By Value
  4. Third Generation DNA Sequencing
    1. By Value
3. By Applications
  1. Introduction
    1. Applications By Value
  2. Oncology
    1. By Value
  3. Clinical investigation
    1. By Value
  4. Agrigenomics & forensics
    1. By Value
  5. HLA typing/immune system monitoring
    1. By Value
  6. Drug development
    1. By Value
  7. Others
    1. By Value
4. By End-User
  1. Introduction
    1. End-User By Value
  2. Academic Research
    1. By Value
  3. Clinical Research
    1. By Value
  4. Hospitals & Clinics
    1. By Value
  5. Pharmaceutical & Biotechnology Companies
    1. By Value
  6. Others
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

DNA Sequencing Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Thermo Fisher Scientific, Inc
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Agilent Technology
Illumina, Inc.
QIAGEN
F. Hoffmann-La Roche Ltd.
Macrogen, Inc.
PerkinElmer Genomics
PacBio
BGI
Bio-Rad Laboratories, Inc.
Myriad Genetics
PierianDx
Partek Incorporated
Eurofins Scientific
Oxford Nanopore Technologies

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment